Another avenue of IL-33 influence is obesity-mediated inflammation in breast carcinoma, inducing the overexpression of IL-33 signaling molecules, which subsequently promote regulatory T cell infiltration, enhancing breast carcinoma aggressiveness [57]. The gene discussed is IL33; the disease is breast carcinoma.